Renal graft function outcomes after conversion from conventional immunosuppression regimen to belatacept plus low dose calcineurin inhibitor regimen: a single center study
Renal graft function outcomes after conversion from conventional immunosuppression regimen to belatacept plus low dose calcineurin inhibitor regimen: a single center study. // Transplantation Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2451959626000132?dgcid=rss_sd_all
Renal graft function outcomes after conversion from conventional immunosuppression regimen to belatacept plus low dose calcineurin inhibitor regimen: a single center study. Transplantation Reports. https://www.sciencedirect.com/science/article/pii/S2451959626000132?dgcid=rss_sd_all
“Renal graft function outcomes after conversion from conventional immunosuppression regimen to belatacept plus low dose calcineurin inhibitor regimen: a single center study.” Transplantation Reports.
@article{article70246,
title = {Renal graft function outcomes after conversion from conventional immunosuppression regimen to belatacept plus low dose calcineurin inhibitor regimen: a single center study},
journal = {Transplantation Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2451959626000132?dgcid=rss_sd_all}
}